Evaluating acupuncture treatment for Alzheimer's disease
Official title: Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease: Multicenter Randomized Controlled Trial
Run by Shanghai University of Traditional Chinese Medicine · NCT03810794 · Data updated 2026-11-12
This study is testing if adding acupuncture to the usual Alzheimer's medication can help improve thinking skills and quality of life for people with mild to moderate Alzheimer's.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 85 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Shanghai University of Traditional Chinese Medicine Academic / other |
| Locations | 3 sites (Shanghai, Shanghai Municipality and 2 other locations) |
| Status | Recruiting |
| Started | March 1, 2019 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | January 6, 2026 |
| Trial ID | NCT03810794 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 50-85 diagnosed with mild to moderate Alzheimer's disease.
✕Probably not a fit
Patients with cognitive impairment due to other factors, such as vascular dementia or metabolic abnormalities, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effectiveness and safety of acupuncture combined with Donepezil in improving cognitive function, daily living abilities, and quality of life in patients with Alzheimer's disease. A total of 180 participants aged 50-85 with mild to moderate Alzheimer's will be randomly assigned to receive either acupuncture alongside Donepezil or Donepezil alone over a 12-week period. The primary outcome will be measured using the ADAS-cog scale, while secondary outcomes will include assessments of cognitive function and quality of life. The study will take place across multiple hospitals in Shanghai.
Why it matters
Potential benefit: If successful, this treatment could enhance cognitive function and quality of life for patients with Alzheimer's disease.
How similar studies have gone: While acupuncture has been explored in various contexts, this specific combination with Donepezil for Alzheimer's is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged between 50-85 years * the diagnostic criteria of Neurological Communicative Disorders and Stroke and the Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) * cognitive impairment based on the scores of the Chinese version of the Mini Mental State Examination (MMSE) (patients with mild to moderate Alzheimers disease, 11≤primary school degree≤22, 11≤junior high school degree or above≤26 * magnetic resonance imaging (MRI) confirmation of atrophy of the hippocampus or the medial temporal lobe volume, MRI manifestation of high possibility of Alzheimer Disease * the Medial Temporal Lobe Atrophy Rating Scale (MTA-scale) score (≥2 for those under 75 years, and ≥3 for those over 75 years) * voluntarily joining this study with informed consents Exclusion Criteria: * cognitive impairment caused by other factors (e.g. vascular dementia, dementia with Lewy bodies, frontotemporal dementia, hormone or metabolic abnormalities, hypothyroidism, folic acid or vitamin B12 deficiency, delirium or other mental and emotional disorders (such as schizophrenia and depression)) * a serious heart condition, hepatic disease, renal system disease, hematopoietic system disease, or whole-body malnutrition * aphasia, disturbance of consciousness, or failure to cooperate with the related examinations due to physical disability * anticoagulant treatments such as warfarin or heparin * use of pacemakers or receiving acupuncture in the past 2 weeks
Where it's running
-
LongHua Hospital Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China Recruiting -
Shanghai Mental Center, Shanghai Jiaotong University of Medicial School
Shanghai, Shanghai Municipality, China Recruiting -
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Jian Pei, Doctor
- Email: jianpei99@hotmail.com
- Phone: 00862164385700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease
A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.
-
Lifestyle for Brain Health — Time-Restricted Eating and Mindfulness
This 9-month program tests whether combining yoga-based mindfulness with time-restricted eating improves cognition, physical fitness, metabolism, and plasma tau levels in adults 60–80 with subjective or mild cognitive impairment and positive pTau217.
-
Nutrition and exercise program for brain health in older adults
This study tests whether a 9-month program of exercise and nutrition can help improve brain health and physical function in older adults at risk for Alzheimer's disease.
-
Hearing care to reduce neuropsychiatric symptoms in people with Alzheimer's and related dementias
This trial will try a tailored, community-delivered hearing care program using HEARS devices to see if it improves communication, reduces neuropsychiatric symptoms, and eases caregiver distress in English-speaking older adults with Alzheimer's disease or related dementias who have untreated hearing loss.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
-
Evaluating acupuncture for Alzheimer's treatment in different genetic groups
This study is testing if acupuncture can help people with mild-to-moderate Alzheimer's disease feel better, especially looking at how it works for those with and without a specific gene.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.